Molecular targeted therapies seem to be a revolutionary approach tocancer treatment and the knowledge of tumor biology needs to be improvedto facilitate the identification of potential new targets. A targeted therapyshould attack a biologically important process preferably one central to ahallmark of cancer. These agents represent a new approach togastrointestinal malignancies as for many other types of tumors.